Issues related to global health programs and research in FY 2024 and FY 2025 Labor Health and Human Services and Education Appropriations Bills
FY 2024 and FY 2025 State and Foreign Operations Appropriations Bills
Issues related to global health research and development
FY 2024 and FY 2025 funding for global health research and development
FY 2024 and FY 2025 Defense Appropriations Bills
FY 2024 and FY 2025 funding for global health research and development programs
Pandemic and All Hazards Preparedness Act Reauthorization
Duration: January 18, 2022
to
present
General Issues: Budget/Appropriations , Health Issues
Spending: about $170,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2022: U.S. Senate
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Venable LLP lobbied for PATH , earning $20,000. The report was filed on April 22.
Original Filing: 301572738.xml
Lobbying Issues
Issues related to global health programs and research in FY 2024 and FY 2025 Labor Health and Human Services and Education Appropriations Bills
FY 2024 and FY 2025 State and Foreign Operations Appropriations Bills
Issues related to global health research and development
FY 2024 and FY 2025 funding for global health research and development
FY 2024 and FY 2025 Defense Appropriations Bills
FY 2024 and FY 2025 funding for global health research and development programs
Lobbying Issues
Pandemic and All Hazards Preparedness Act Reauthorization
4th Quarter, 2023
In Q4, Venable LLP lobbied for PATH , earning $20,000. The report was filed on Jan. 20.
Original Filing: 301533803.xml
Lobbying Issues
Issues related to global health programs and research in FY 2024 Labor Health and Human Services and Education Appropriations Bills
FY 2024 State and Foreign Operations Appropriations Bills
Issues related to global health research and development
FY 2024 funding for global health research and development
FY 2024 Defense Appropriations Bills
FY 2024 funding for global health research and development programs; FY2025 funding for global health research and development
Lobbying Issues
Pandemic and All Hazards Preparedness Act Reauthorization
3rd Quarter, 2023
In Q3, Venable LLP lobbied for PATH , earning $20,000. The report was filed on Oct. 18, 2023.
Original Filing: 301503555.xml
Lobbying Issues
Issues related to global health programs and research in FY 2024 Labor Health and Human Services and Education Appropriations Bills; FY 2024 State and Foreign Operations Appropriations Bills; Issues related to global health research and development; FY 2024 funding for global health research and development; FY 2024 Defense Appropriations Bills; FY 2024 funding for global health research and development programs.
Lobbying Issues
Pandemic and All Hazards Preparedness Act Reauthorization; PASTEUR Act
2nd Quarter, 2023
In Q2, Venable LLP lobbied for PATH , earning $20,000. The report was filed on July 19, 2023.
Original Filing: 301484830.xml
Lobbying Issues
Issues related to global health programs and research in FY 2024 Labor Health and Human Services and Education Appropriations Bills; FY 2024 State and Foreign Operations Appropriations Bills; Issues related to global health research and development; FY 2024 funding for global health research and development; FY 2024 Defense Appropriations Bills; FY 2024 funding for global health research and development programs.
Lobbying Issues
Pandemic and All Hazards Preparedness Act Reauthorization; PASTEUR Act; HR 1305 SUPER BUGS Act
1st Quarter, 2023
In Q1, Venable LLP lobbied for PATH , earning $20,000. The report was filed on April 20, 2023.
Original Filing: 301463270.xml
Lobbying Issues
Issues related to global health programs and research in FY 2024 Labor Health and Human Services and Education Appropriations Bills; FY 2024 State and Foreign Operations Appropriations Bills; Issues related to global health research and development; FY 2024 funding for global health research and development; FY 2024 Defense Appropriations Bills; FY 2024 funding for global health research and development programs.
Lobbying Issues
Pandemic and All Hazards Preparedness Act Reauthorization; PASTEUR Act; HR 1305 SUPER BUGS Act
4th Quarter, 2022
In Q4, Venable LLP lobbied for PATH , earning $20,000. The report was filed on Jan. 19, 2023.
Original Filing: 301435732.xml
Lobbying Issues
Issues related to global health programs and research in FY 2023 Labor Health and Human Services and Education Appropriations Bills; FY 2023 State and Foreign Operations Appropriations Bills; Issues related to global health research and development; FY 2023 funding for global health research and development; FY 2023 Defense Appropriations Bills; FY 2024 funding for global health research and development programs.
Lobbying Issues
Pandemic and Covid-19 preparedness; S. 3799 PREVENT Pandemics Act; CURES 2.0 legislation; H.R. 5585 - ARPA-H Act; Pandemic and All Hazards Preparedness Act Reauthorization.
3rd Quarter, 2022
In Q3, Venable LLP lobbied for PATH , earning $20,000. The report was filed on Oct. 19, 2022.
Original Filing: 301410157.xml
Lobbying Issues
Issues related to global health programs and research in FY 2023 Labor Health and Human Services and Education Appropriations Bills; FY 2023 State and Foreign Operations Appropriations Bills; Issues related to global health research and development; FY 2023 funding for global health research and development; FY 2023 Defense Appropriations Bills; FY 2024 funding for global health research and development programs.
Lobbying Issues
Pandemic and Covid-19 preparedness; S. 3799 PREVENT Pandemics Act; CURES 2.0 legislation; H.R. 5585 - ARPA-H Act.
2nd Quarter, 2022
In Q2, Venable LLP lobbied for PATH , earning $20,000. The report was filed on July 20, 2022.
Original Filing: 301388814.xml
Lobbying Issues
Issues related to global health programs and research in FY 2023 Labor Health and Human Services and Education Appropriations Bills; FY 2023 State and Foreign Operations Appropriations Bills; Issues related to global health research and development; FY 2023 funding for global health research and development; FY 2023 Defense Appropriations Bills.
Lobbying Issues
S. 2640 - Disease X Act; Pandemic and Covid-19 preparedness; S. 3799 PREVENT Pandemics Act; CURES 2.0 legislation; H.R. 5585 - ARPA-H Act.
1st Quarter, 2022
In Q1, Venable LLP lobbied for PATH , earning $10,000. The report was filed on April 20, 2022.
Original Filing: 301368500.xml
Lobbying Issues
Issues related to global health programs and research in FY 2022 Labor Health and Human Services and Education Appropriations Bills; FY 2022 State and Foreign Operations Appropriations Bills; FY 2022 Defense Appropriations Bills; FY 2022 National Defense Authorization Act; FY 2022 budget global health research and development issues; Issues related to global health research and development; FY 2023 funding for global health research and development.
Lobbying Issues
S. 2640 - Disease X Act; Pandemic and Covid-19 preparedness; S. 3799 PREVENT Pandemics Act.
1st Quarter, 2022
Venable LLP filed a lobbying registration on March 28, 2022 to represent PATH, effective Jan. 18, 2022.
Original Filing: 301343056.xml
Issue(s) they said they’d lobby about: Funding for global health research and development; 21st Century Cures 2.0; S. 2640 - Disease X Act; Pandemic and Covid-19 preparedness .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate